Skip to main content
. 2022 Jun 20;39(9):e14898. doi: 10.1111/dme.14898

FIGURE 3.

FIGURE 3

Proportional receipt of each glucose‐lowering drug as an add‐on glucose‐lowering drug class by calendar year. AGi, Alpha Glucosidase inhibitor; DPP4i, Dipeptidyl peptidase‐4 inhibitor; GLP‐1 RA, Glucagon‐like peptide‐1 receptor agonist; SGLT2i, Sodium‐glucose co‐transporter 2 inhibitor.